Levosimendan Versus Milrinone to Support Hemodynamics During Off Pump Coronary Artery Bypass Grafting Surgery in Patients With Poor Ejection Fraction
Latest Information Update: 03 Mar 2021
At a glance
- Drugs Levosimendan (Primary) ; Milrinone
- Indications Coronary artery disease
- Focus Therapeutic Use
Most Recent Events
- 05 Mar 2019 Status changed from not yet recruiting to recruiting.
- 05 Mar 2019 New trial record